Sparing of Methionine Requirements: Evaluation of Human Data Takes Sulfur Amino Acids Beyond Protein
Open Access
- 1 June 2006
- journal article
- review article
- Published by Elsevier in The Journal of Nutrition
- Vol. 136 (6) , 1676S-1681S
Abstract
The intimate relation between amino acids and protein and nitrogen requirements is well recognized. Nutrition research has focused on the capacity of food to meet the need for nitrogen and indispensable amino acids (IAA) and led to the conclusion that the quality, not just the quantity, of protein is critical. This is especially relevant in regard to the sulfur amino acids (SAA) methionine and cysteine because of the increased understanding of their relation to chronic diseases (e.g., cardiovascular disease, dementia, cirrhosis), immunomodulation, DNA transcription, and RNA translation. Considerable effort has been expended to determine whether and to what extent cysteine can spare the requirement for the IAA methionine. In vivo studies in humans generally concur that the dietary requirement of the SAA ranges between 13 and 16 mg·kg−1·d−1, but how much can be met by cysteine relative to methionine remains controversial. This review examines the current status of in vivo estimates of methionine and cysteine requirements in human adults and considers needs beyond what is necessary for protein synthesis. Factors influencing the utilization of methionine and cysteine, especially those conditions that lead to toxicity on the one hand or beneficial effects on the other, are discussed. Data on alternative dietary sources of methyl groups (e.g., betaine, choline, phosphatidylcholine, S-adenosylmethionine, S-methylmethionine) or sulfur (e.g., N-acetylcysteine or L-2-oxothiazolidine-4-carboxylic acid) support a role for the SAA “beyond protein.” Other pathways may influence the specific requirement for methionine and/or cysteine, especially when the person is challenged by disease, inadequate availability of food, or environmental stress.Keywords
This publication has 67 references indexed in Scilit:
- A Prodrug of Cysteine, l-2-Oxothiazolidine-4-carboxylic Acid, Regulates Vascular Permeability by Reducing Vascular Endothelial Growth Factor Expression in AsthmaMolecular Pharmacology, 2005
- Nutrigenomics and nutrigenetics: the emerging faces of nutritionThe FASEB Journal, 2005
- Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stressBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- The vegetarian lifestyle and DNA methylationClinical Chemistry and Laboratory Medicine (CCLM), 2005
- The Feast of the AssumptionsPublic Health Nutrition, 2004
- N-Acetylcysteine improves the disturbed thiol redox balance after methionine loadingClinical Science, 2003
- GENETICEFFECTS OFMETHYLATIONDIETSAnnual Review of Nutrition, 2002
- Antidiabetic Effect of a Prodrug of Cysteine,l-2-Oxothiazolidine-4-carboxylic Acid, through CD38 Dimerization and InternalizationJournal of Biological Chemistry, 2002
- The glutathione precursor l-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the ratHepatology, 2000
- Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteineEuropean Journal of Clinical Pharmacology, 1988